Interventional Cardiologists, Cardiologists, Cardiovascular Surgeons, Nurse Practitioners, Physician Assistants, Nurses, Cardiovascular Lab Techs, Hospital Administrators
• Understand the interventional approaches for TAVR and indications for cerebral protection in these patients.
• Evaluate the evolution of tricuspid valve intervention and review the indications for percutaneous mitral valve replacement.
• Review the evidence that all patients with CHADS2 score should have LAA occlusion.
• Evaluate new stent technology including CeloNova, BioNir and bioresorbable scaffolds for all anatomic subsets.
• Manage extended DAPT therapy after PCI using insights from recent trials.
• Evaluate new approaches for the STEMI patient, including radial approach, mechanical complications and management of multiple vessel disease.
• Discuss indications for CTO recanalization, evidence that it improves long term outcomes, its unique complications and their management.
• Discuss the rationale for LV support for CHIPs patients and the long term implications of complete revascularization.
• Evaluate the use of IVUS and FFR in patients with CTO or unprotected left main disease.
• Understand aggressive management of risk factors for severe vascular disease.
• Review imaging techniques for SCAD patients, their acute management and long term outcomes.
• Understand venous stenting, who needs it, and how to do it.
• Manage patients who are surgical turndowns and patients who are post SVG failures.
• Discuss interventional dilemmas and review complications and outstanding PCI results in all patient subsets.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Cardiovascular Institute of the South (CIS) and Saint Luke’s Hospital Foundation. CIS is accredited by the ACCME to provide continuing medical education for physicians.
Cardiovascular Institute of the South designates this live activity for a maximum of 19.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is the policy of Cardiovascular Institute of the South to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All those in control of the content are required to disclose all relevant financial relationships with any commercial interest, their intention to discuss off-label or investigational use, and to attest to the validity of their scientific research and recommendations involving clinical medicine.
The intent of this policy is to resolve any conflict of interest prior to developing the educational activity by (1) identifying the relationship, (2) instructing speakers to base clinical recommendations on the best available evidence, and (3) submitting content for peer review during development to ensure it is clinically valid, based on generally accepted scientific research, and aligned with the interests of
the public. Education content, faculty selection and presentations are not influenced by commercial entities. Complete disclosure information will be included with activity handouts and available at the onsite Registration Desk.